Owc Pharmaceutical Research Corp. (OWCP) SEC Filing 8-K Material Event for the period ending Monday, October 7, 2019

Owc Pharmaceutical Research Corp.

CIK: 1431934 Ticker: OWCP

View differences made from one to another to evaluate Owc Pharmaceutical Research Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Owc Pharmaceutical Research Corp..


Assess how Owc Pharmaceutical Research Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Owc Pharmaceutical Research Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: OWCP
CIK: 1431934
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-015116
Submitted to the SEC: Mon Oct 07 2019 9:15:14 AM EST
Accepted by the SEC: Mon Oct 07 2019
Period: Monday, October 7, 2019
Industry: Surgical And Medical Instruments And Apparatus
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: